KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Current Deferred Revenue (2016 - 2025)

Repligen (RGEN) has disclosed Current Deferred Revenue for 14 consecutive years, with $15.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue changed N/A to $15.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $15.7 million, a N/A change, with the full-year FY2024 number at $13.2 million, changed N/A from a year prior.
  • Current Deferred Revenue was $15.7 million for Q3 2025 at Repligen, down from $20.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $28.0 million in Q3 2023 to a low of $13.2 million in Q4 2024.
  • A 5-year average of $18.9 million and a median of $19.3 million in 2022 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: fell 3.07% in 2021, then increased 29.87% in 2022.
  • Repligen's Current Deferred Revenue stood at $14.8 million in 2021, then increased by 29.87% to $19.3 million in 2022, then surged by 44.97% to $28.0 million in 2023, then tumbled by 52.63% to $13.2 million in 2024, then grew by 18.41% to $15.7 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Current Deferred Revenue are $15.7 million (Q3 2025), $20.8 million (Q2 2025), and $13.2 million (Q4 2024).